This notion is supported by several recent studies providing experimental evidence that tamoxifen or fulvestrant treatment of HNSCC cell lines increases apoptosis [13], reduces invasion in combination with EGFR inhibition [13], and sensitizes tumor cells to fractionated irradiation [14]. Here, EGFR is linked to head and neck squamous cell carcinoma.